Abstracts Vol. 1 [International Conference on AIDS (11th: 1996: Vancouver, Canada)]

blood donors
Mo.A. 004, Mo.B. I1146, No.B.1 147,
Mo.B. 1148, Mo.B. 1149, No.B. 1150,
Na.120, Na.121, Ma.C. 124,
MoC. 1424, Ma.C. 1470, MaoC. 1499,
Ma.C. 1533, Ma.C. I1622, Pub.B. 1033,
Pub.B. 1042, Pub.C. I 11I3, Pub.C. 1135,
Pub.C. 11I39, Pub.C. 1 159, Pub.C. I1176,
Pub.C. 1177, Pub.C. 11I78, Th.A.4056,
Th.B.4 I160, Th.C.4450, Tu.C.223,
Tu.C.2562, Tu.C.2564, Tu.C.2566,
Tu.C.2689, We.A.3020, We.B.3 196,
We.C.3426, We.C.3432, We.C.3572,
We.C.3573, We.C.3576
blood flow
Th.A.4044
blood products
Mo.B. I I151, No.8.1 152, Ma.C. 122,
Pub.C. I1I39, Th.B. I175, Th.C.47 I11,
Th.D.4922, We.D.3876, We.D.3877,
We.D.3878, We.D.3879, We.D.388 I
blood transfusions
Mo.B. 1334, Mo.C. 121, Ma.C. 124,
MoC. 125, Pub.B. 1033, Pub.C. 11I39,
Pub.C. I1176, Pub.C. I1269, Tu.A.2 I 10,
Tu.C.2562,Tu.C.2564, We.C.3469,
We.C.3573, We.C.3578, We.D.388 I
blood-brain barrier
Mo.C. 1452, Ma.C. 1477, Pub.A. 1006,
Th.C.4749,Tu.A. 143
bloodborne infections
Mo.B.121 1, Mo.B. 1323, Ma.C. 121,
Pub.C. 18,278,Tu.C. I124, Tu.C. 125,
Tu.C.2563, We.C.3432, We.C.35 I17,
We.C.3574, We.C.360 I
bone marrow
Mo.B. I 367,Tu.B.2226, We.B.3242
bone marrow transplantation
Mo.A.382, Mo.B. 1 292, Tu.B.52 I
brain, SEE central nervous system
Tu.B.2268, We.A. 155, We.B.3209
breast milk
Tu.C.2605
breastfeeding, SEE also vertical
transmission
Mo.B. 1304, Th.C.4 I15, Tu.B.2 173,
Tu.C.2605,Tu.C.342, We.C.3583
broncho-alveolar lavage
Tu.B. 11I5,Tu. B.2 19 3, Tu. B.229 6,
We.A.3043, We.A.384, We.B.322 1,
We.B.33 IS
bronchoscopy
T.D.5027,Tu.B.2 I146, We.B.33 I S,
We.B.33 16, We.B.3322, We.C.342 I
Burkitt's lymphoma
Mo.B.1292, Na.B.433,Th.B.4224
burnout, SEE health care personnel
Th.D.5096, We.D.250, We.D.25 1,
We.D.3860, We.D.3865, We.D.3867,
We.D.3868, We.D.3873
cachexia, SEE also wasting syndrome
Mo.B. I1384, Mo.B. I 397,Tu.B.2377,
Tu.B.2379,TuB.2380,Tu.B.2387,
We.B.3265
calorimetry, indirect
Mo.B. I1389, We.B.3266
campaign

We.B.3243, We.B.3322, We.C.34 12

candidiasis
Mo.B. 12, Mo.B. 123 3, No.B. I1334,
Pub.B. 1070, Pub. D. 1458, fh.A.4057,
Th.A.4067,i1 h.A 40/0,113h.6 4205,
Th.B.4207,Tu.62 I194, Jo 6 2 98.
Tu.B.2200, We /\. 3050, \ VeB32 19,
We.B.3223,We I0 33W3, Ve.B.3304,
We.B.3305
candidiasis, esophageal
No.8. I I I, No.['. 116, MNeTS228,
No.8. 1229,Tu.B.2 I;94
candidiasis, mucocucaneous
No.8.1 229, Tu.B.2 197,22u.0.41 1
We.B.3223, We.I'3 305, We.C.3408
candidiasis, vaginal
No.C. 1637,11.04 40, We 18.3 136,
We.B.31I90, We.1532 /6,//e 14 t03 281I
We.C.3402
capsid protein
We.A. 154
care, models of
No.8. 1154, No.B. i I159, N'o.13. I161,
N o.8B. I1I62, MNo.8. II64, 1No.B. 131 2,
No.8.1I9 I, No..I/8 I, No.11.230,
No.D.232, Pub..1038, Pub C. 125 I,
Pub.D. I1381I, Pub.D.! 382, Pub.D. I1427,
Pub.D. I 500,Th.B. 190, TfOB. 191, Th.B.400,
Th.B.40 I,Th.B.404 11.6 4 1I13, Th.B.4 114,
Th.B.4 II 6,Th.B.4 I27, T 0.8.4130,
Th.C.4383, Th.C.4o3 3, Thi.C.4634,
Th.C.4679, Th.C. 4758,'11,.0.4782,
Th.C.48 I15, Th.C.4844, Th.D. 130,
Th.D. I133, Th.D.257, 3h.1.4860,
Th.D.4873,Th.D.488 I, 13 0974,
Th.D.5003,TO.D.5008, 101.1.5046,
Th.D.5 I106, Tu. B.2 I1'61, T6.13.2 149,
Tu.C.21I l,Tu.C.267/, [u.D.2761,
Tu.D.2762,Tu.D.2840, 1u.D.2850,
Tu.D.294 I, We.B. I170, We.B.3 142,
We.B.3 IS I, We.B.3263, We.6.33 I13,
We.D.3634, We.Ii.3659, We 1.3675,
We.D.3686, Wei) 3687, We.D.3688,
We.D.3690, We.[3.3696, We D.3708,
We.D.37 I18, We.L).372', We.D.3/25,
We.D.3732, We.[).37-1, We [9.3741I,
We.D.3860, We.D.3872+ We.D.600,
We.D.602, We.L3.603, SVe.l ).61I2
caregivers, family
No.8.55 1, No.D. 137, No.L).230,
No.D.23 I, No.D.233,NoD2,
No.D.37 I, Pub.B. 1039, PuO.B. 1074,
Pub.C. 1237, PuL.D. I290, PuO.D. I1306,
Pub.D. 1339, Pub.D. I13/9.PuOD). 1484,
Pub.D.1486, Pub.6.148,,B.41 19,
T1.C.4639, Th.D.4 882, -3[0.4888,
T1.D.4892, T1.D.4896, T1.D.5093,
T1.D.5096,T13.D.5 I08,3h133.5 i /5,
Tu.B.2 I 43,Tu.D.2 /53, fu.)94 1,
We.D.3624, We.D.3640. We.D.365,
We.D.3705, We.D.37) 3, We.[).3 /36,
We.D.374, We.D.38 I2, We.D.3880,
We.D.612
caregivers, non-family
Mo.B.55 I, No.D. 1744, No.13.2.3,
ub.B. 1074, ub.D. I1290, uh.[0 I1331,
ub.D. I1382, ub.D. 1458, uh.D. 1487,
T1.C.4636, Th.C.4 7 I I, T.C.4843,

Tu.B.2 161,Tu.B.2303, 22.2/62,
We.B.3 I44, We.B.3 I154VWe.6.3256,

We.B.3256, We.D.37 I18, We.D.3725,
We.D.3852, We.D.3878
case-control study
No.8.1216, No.8.434, Ma.C. 1623,
Pub.C. I1178, Pub.D. I1469, T1.D.5 158.
Tu.B. I 86,Tu.B.2298,Tu.C.2390,
Iu.C.2688, Tu.C.552, We.B.3230,
We.B.3235, We.C.22 I
castanospermine (CAS)
No.8. 1138, No.8. 1145, No.B. 1329
casual transmission
Ma.C,1461, Pub.C. I 269, Tu.C. 120,
Tu.C.2633,Tu.D.2948, We.A.3009
catheters
No.8. 1383, We.B.3204, We.B.3205
CD28 surface antigen
T1.A.4002,Tu.A.2 I 08,Tu.A.38 I,Tu.A.383,
Tu.A.384, We.A.3074, We.A.405
CD3 antigen
Tu.A.380, We.A.3074, We.A.405
CD344- multipotential progenitor cells
T1.A.4006, Th.A. 140, We.A.27 I,
We.A.273, We.B.3 181
CD4, anti-idiotype antibodies
We.B.294
CD4, binding
No.A. 1008, No.A. 1010, No.A. 1058,
[h.A. I 52.11.8.4 179, We.A.3004
CD4 lymphocytes
No.A. 107 1, No.A.5 13, No.8. 1122,
No.8. 1128, No.8. 113 1, No.8. 11I33,
No.8. 1143, No.8. 1180, No.8.1233,
No.8. 1269, No.8.1294, No.8.1 336,
No.8.1346, No.8.1351, No.8. 1352,
No.8. 137 1, No.8. 1386, No.8. 180,
No.8.181, No.8.543, Ma.C,1459,
Mu.1493, Ma.C. 1502, Ma.C. 1529,
Ma.C.1IS35, Ma.C. 1S43, Ma.C. 1545,
Ma.C. ISSI, Ma.C. 1S60, Ma.C. 1573.
NaGC. 183, Ma.C, 1603, No.C.325,
No.D.l1768, Pub.A. 1012, Pub.B.l05I,
Pu1.B.1083, Pub.B. 1085, Pub.C.lI 112,
Th.A. I147, T1.A.4006, Th.A.4008,
Th.A.4009, Th.A.40 I15, T1.A.40 19,
Th.A.4020,Th.A.402 I,T1.A.4022,
Yh.A.4025, T1.A.4032, Th.A.403 3,
Th.A.404 I,11.A.4045,Th.A.408 I,
Yh.A.4082,T1.A.4084, Th. B.294,
1-h.B.4097, T.B.4098,T3.B.4 103,
Th.8B.4 106, Th3.B.4 I108,1Th.8B.418 3,
1h.8B.4 190, Th.80AA29 3,Th3.B.4294,
11..4295. Th.B.4296, T13..2 14,
Th.C.223,T1..4368,Th.G.482 I,
I'u.A.2003, Tu.A.2006, Tu.A,2024,
Tu.A.202 7, Tu.A.2038, Tu.A.2040,
Tu.A.204 I, Tu.A.2046, Tu.A.2060,
1lu.A.2066, Tu.A.2080, Tu.A.270, Tu.A,274,
Th.A. 384, Tu. B.2 I1I8, Tu. B.2 I125, Tu. B.21I26,
Tu. B.2 I180, Tu. B.2 I194, Tu. B.2205,
Tu. B.22 I10, Tu. B.22 I16, Tu. B.22 17,
lu.B.2233,Tu.B.2240,Tu.B.224 I,
Tu.B.2246,Tu.B.225 I,Tu.B.2296,
l u. B.2 344, Tu. B.23 46, Tu. B.2349,
Tu.B.237 I,Tu.B.4 I 5,Tu.B.522, fu.G.2598,
Tu.G.44 I, We.A. I104, We.A.264,
We.A.28 1, We.A.3006, We.A.303 I,
We.A.3047, We.A.3053, We.A.3054,

CD4, molecule
No.A. 1001, No.A, 1009, No.8. 1352,
Ma.C. 1535, Pub.A. 1016, 1.8.4179,
Tu.A.380
CD4, other
Pub.B. I1058, T. B.4280, Th. B.43 35,
11..4336,113.8.4337, ]u.B.2244,
Tu.B.2337,Tu.B.2349, We.C.3459
CD4, peptides
We.A.3030
CD4, soluble
Tu.A.201 I, We.B.3349
CD4, soluble recombinant
No.A, 1091, No.A. 1093
CD8
No.8.1354, No.8.180, Ma.C, 1493,
Ma.C. 1603, No.C.32 I, Pub.A. 1012,
Pub.C.l I112, T1.A.I00, T1.A.101,
Th.A. I102, T1.A.400 I, Th.A.4002,
T1.A.4008,T1.A.4020,T13.A.402 I,
T1.A.4025, Th.B.4098, Th3.B.4285,
Th.B.4296, Tu.A.2024, Tu.A.2038,
Tu.A.38 I,Tu.A.382, 1u.A. 384, Tu.A. 3 9 3
Tu.B.22 I 0,Tu.B.2345, We.A.3053,
We.A.3054, We.A.306 1, We.A.3072,
We.A.3076, We.A. 3082, We.A. 3085,
We.A.3088, We.A.3 I102, We.B.29 I,
We.B.3 I127, We.B.3 I199, We.B.3326,
We.G.3464
CD8, cytotoxic cells
No.8.1282, No.8.1284, No.8.1335,
No.8. 14 354,T13.A. I103, T1.A. I 04, Th.A. 140,
Th.A. I144, T1.A. I147, T1.A.400 I,
Th.A.4059, Th.B8.4297, Tu.A.28 I,
Tu.B,2330, We.A. 102, We.A.300 1,
We.A.3008, We.A.3029, We.A.3035,
We.A.3036, We.A.3066, We.A.380,
We.A.382, We.A.403, We.B.3382,
We.B.553, We.D.3794
CD8, suppressor cells
No.A.393, Pub.A, 10 1 2,T13.A. 101,
Th.A. I 05,Th.B.4287,Tu.A.390,Tu.A.39 I,
Tu.A.392, Tu.A. 395, Tu.A.503, Tu. B.23 30,
Tu.B.40 I, We.A.3034, We.A.3066,
We.A.500, We.B.3347, We.B.3350
CD8(+) T cells, activated autologous
No.AI I117, T1.A.380, T1.B.173,
Tu.A.2020, Tu.A.2028, Tu.A.50 I,
We.A.3070, We.A.383
cell entry
No.A. 1002, No.A, 1010, No.A. lOSS,
Mo.A. I1070, T1.A. I152, Tu.A.2023,
We.A.3004, We.B.)129
cell fusion
No.A, 1010, No.A. 1055, No.A, 1070,
Th.A. I152, Tu.A.263, We.A. I100, We.A, 151,
We.A. I156, We.A.26 I
cell killing
Na.A. 1096, Mo.A. I 098,Tu.A.203 I,
Tu.A.2038, Tu.A.2040, We.A. 102,
We.A.260, We.A.26 I, We.A.262,
We.A.3005, We.A.3068
cell markers
Th.A. 10 1,T1.A.402 I,Th.A.4025,
Tu.A.2003, Tu.A.2027,Tu.B.23 13,
Tu.B.2330,Tu.B.2344, We.A.3053,
We.A.3055, We.A.3066

Tu.A.28 I, TuA.282, Tu.A.395, TuA, 503,
We.A.300 I, We.A.3033, We.A.30 S I,

\O
0
u
c
0
a)
0
a)
c
478